Posted On: 03/04/2016 7:12:39 PM
Post# of 72447
Re: NotRichYet2 #19481
Along another line of thought to what notrichyet inquired about today, I am reposting this link for "expanded access". It is the protocol by which the FDA allows drugs still in clinical trials to be used in patients outside the trial because it may be of benefit, ie. "compassionate use".
As I have previously stated, Kevetrin may become well known among the cancer patient communities resulting in an UNFORSEEN demand and subsequent catalyst. What makes this so interesting to me is that "they" cannot anticipate it and cannot downplay it. It is a true catalyst that can happen at anytime but more than likely once we start the Kevetrin Phase II trials.
As I have previously stated, Kevetrin may become well known among the cancer patient communities resulting in an UNFORSEEN demand and subsequent catalyst. What makes this so interesting to me is that "they" cannot anticipate it and cannot downplay it. It is a true catalyst that can happen at anytime but more than likely once we start the Kevetrin Phase II trials.
(0)
(0)
***On 02/26/2016 at 8:33 am Scottsmith admited to posting under 5 aliases but his post was subsequently deleted. I have a screen shot and will email it to anyone interested.
